Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUTERA INCCUTR · Entity 82936 | Director | July 15, 2024 | July 17, 2024 |
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Director | August 05, 2025 | August 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUTERA INC
Report date July 15, 2024 · Filed July 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.55 · Expires 2029-06-16 | Direct | 0 |
Reported balance
After 2024-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-07-15 · Disposition to issuer · Disposed 3,627 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.54 · Expires 2029-06-16 | Direct | 3,627 |
Reported balance
After 2024-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-07-15 · Grant · Acquired 3,627 · Balance 3,627 F1: On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.83 · Expires 2030-07-14 | Direct | 0 |
Reported balance
After 2024-07-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-15 · Disposition to issuer · Disposed 7,770 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.54 · Expires 2030-07-14 | Direct | 7,770 |
Reported balance
After 2024-07-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-07-15 · Grant · Acquired 7,770 · Balance 7,770 F1: On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
Prestige Consumer Healthcare Inc.
Report date August 05, 2025 · Filed August 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 30,123 |
Reported balance
After 2025-08-05 transaction · row 1
1 source rowRow 1 · 2025-08-05 · Grant · Acquired 2,094 · Balance 30,123 F1: The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2025 Filed Aug 6, 2025 20:03 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-074704 · tm2522759-4_4seq1.xml · nonDerivative · entry 1 Hopkins Sheila · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,123 F1 · shares: The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:05 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-086751 · tm2421115-6_4seq1.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,029 F1 · shares: The Reporting Person received 2,202 restricted stock units equal to $150,000 divided by the closing stock price of $68.13 on August 6, 2024, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:32 UTC | CUTERA INC CUTR · Entity 82936 | GrantStock Option (Right to Buy) · Derivative | 7,770 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0001628280-24-032155 · wk-form4_1721266356.xml · derivative · entry 4 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,770 Underlying: COMMON STOCK · 7,770 shares Expires 2030-07-14 F1 · derivative.exercise_price: On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:32 UTC | CUTERA INC CUTR · Entity 82936 | Disposition to issuerStock Option (Right to Buy) · Derivative | 7,770 | $0.00 Strike: $15.83 | $0.00 |
DisclosureSEC source: 0001628280-24-032155 · wk-form4_1721266356.xml · derivative · entry 3 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 7,770 shares Expires 2030-07-14 Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:32 UTC | CUTERA INC CUTR · Entity 82936 | GrantStock Option (Right to Buy) · Derivative | 3,627 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0001628280-24-032155 · wk-form4_1721266356.xml · derivative · entry 2 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,627 Underlying: COMMON STOCK · 3,627 shares Expires 2029-06-16 F1 · derivative.exercise_price: On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:32 UTC | CUTERA INC CUTR · Entity 82936 | Disposition to issuerStock Option (Right to Buy) · Derivative | 3,627 | $0.00 Strike: $36.55 | $0.00 |
DisclosureSEC source: 0001628280-24-032155 · wk-form4_1721266356.xml · derivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 3,627 shares Expires 2029-06-16 Read SEC document |
| May 13, 2024 Filed May 14, 2024 18:58 UTC | CUTERA INC CUTR · Entity 82936 | Tax withholdingCOMMON STOCK | 7,722 | $2.04 | $15,752.88 |
DisclosureSEC source: 0001628280-24-023339 · wk-form4_1715727487.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,004 F1 · shares: Represents the total number of shares withheld by the Company to settle the Reporting Person's tax liability for 17,085 Restricted Stock Units vesting on May 13, 2024. Such withholding is required by the Company's 2019 Equity Incentive Plan. Read SEC document |
| May 13, 2024 Filed Jun 4, 2024 15:41 UTC Amendment | CUTERA INC CUTR · Entity 82936 | Tax withholdingCOMMON STOCK | 0 | $2.04 | $0.00 |
DisclosureSEC source: 0001628280-24-026538 · wk-form4a_1717530063.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,726 F1 · shares: The Company did not withhold 7,722 shares for the Reporting Person's tax liability as previously reported in the Form 4 filed on 5/14/2024, instead the shares were released directly do the Reporting Person at the Reporting Person's request. F2 · balance_after: The Reporting Person's beneficial ownership should have been reported as 45,726 shares. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 16:19 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON STOCK | 6,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044212 · doc4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,219 F1 · shares: Grant of Restricted Stock Units (RSU's) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The 6,368 shares shall vest on August 1, 2024, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 18:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-087190 · tm2322776-4_4seq1.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,827 F1 · shares: The Reporting Person received 2,295 restricted stock units equal to $150,000 divided by the closing stock price of $65.37 on August 1, 2023, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| July 14, 2023 Filed Oct 18, 2023 16:18 UTC | CUTERA INC CUTR · Entity 82936 | GrantStock Option (Right to Buy) · Derivative | 7,770 | $0.00 Strike: $15.83 | $0.00 |
DisclosureSEC source: 0001209191-23-053074 · doc4.xml · derivative · entry 2 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,770 Underlying: Common Stock · 7,770 shares Expires 2030-07-14 F2 · derivative.exercise_date: Grant of stock options that will entitle the Reporting Person to receive one share of Common Stock per one option. The stock options vest upon the conclusion of the Cutera, Inc. 2024 Annual General Meeting of Stockholders, expected to occur in June 2024. Read SEC document |
| July 14, 2023 Filed Oct 18, 2023 16:18 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON STOCK | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-053074 · doc4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,726 F1 · shares: Grant of Restricted Stock Units (RSU's) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The RSUs vest upon conclusion of the Cutera 2024 Annual General Meeting of Stockholders, expected to occur in June 2024. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 16:33 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON STOCK | 8,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041551 · doc4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,851 F1 · shares: Grant of Restricted Stock Units (RSU's) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The 8,170 shares shall vest on July 3, 2024, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 16:15 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON STOCK | 17,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-014577 · wf-form4_168297213405740.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,681 F1 · shares: Grant of Restricted Stock Units (RSU's) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The 17,085 shares shall vest on April 27, 2024, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 21:20 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-085715 · tm2222537-6_4seq1.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,532 F1 · shares: The Reporting Person received 2,495 restricted stock units (equal to $150,000 divided by the closing stock price of $60.12 on August 2, 2022) in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 18:23 UTC | CUTERA INC CUTR · Entity 82936 | GrantStock Option (Right to Buy) · Derivative | 3,656 | $0.00 Strike: $36.55 | $0.00 |
DisclosureSEC source: 0001628280-22-017492 · wf-form4_165550460900926.xml · derivative · entry 2 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,656 Underlying: COMMON STOCK · 3,656 shares Expires 2029-06-16 F2 · derivative.exercise_date: Grant of stock options that will entitle the Reporting Person to receive one share of Common Stock per one option. The stock options vest upon the conclusion of the Cutera, Inc. 2023 Annual General Meeting of Stockholders expected to occur on or about June 15, 2023. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 18:23 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON STOCK | 1,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-017492 · wf-form4_165550460900926.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,596 F1 · shares: Grant of Restricted Stock Units (RSUs) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The RSUs vest upon the conclusion of the Cutera, Inc. 2023 Annual General Meeting of Stockholders expected to occur on or about June 15, 2023. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-100936 · tm2124298-4_4seq1.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,037 F1 · shares: The Reporting Person received 2,808 restricted stock units (equal to $150,000 divided by the closing stock price of $53.42 on August 3, 2021) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| May 17, 2021 Filed May 19, 2021 18:21 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON STOCK | 8,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034135 · doc4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,208 F1 · shares: Grant of Restricted Stock pursuant to the Issuer's 2019 Equity Incentive Plan. One-third of the shares vest on May 17, 2022 and each one-year anniversary thereafter. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 21:24 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-091550 · tm2023357d6_4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,229 F1 · shares: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.36 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:27 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 4,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-037212 · tv526532_4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,497 F1 · shares: The Reporting Person received 4,183 restricted stock units (equal to $145,000 divided by the closing stock price of $34.67 on July 30, 2019) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-041352 · tv499906_4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,314 F1 · shares: The Reporting Person received 3,770 restricted stock units (equal to $135,000 divided by the closing stock price of $35.73 on July 31, 2018) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 19:32 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-040284 · v472275_4.xml · nonDerivative · entry 1 HOPKINS SHEILA · CIK 0001248574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,535 F1 · shares: The Reporting Person received 2,564 restricted stock units (equal to $135,000 divided by the closing stock price of $52.64 on August 1, 2017) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.